1887

n Cardiovascular Journal of South Africa - ASCOT - trial hypertensives with normal to elevated cholesterol levels : drug trends in cardiology

USD

 

Abstract

Extracted from text ... ASCOT - trial hypertensives with normal to elevated cholesterol levels Pfizer Inc. announced recently that initial results from a major clinical trial involving its cholesterol-lowering medicine Lipitor(r) (atorvastatin calcium) showed that Lipitor provided a significant benefit in reducing fatal and non-fatal heart attacks as well as strokes. The study, known as the Anglo- Scandinavian Cardiac Outcomes Trial (ASCOT) involving nearly 20 000 patients with high blood pressure, was designed to compare the effects of newer anti-hypertensive medicines with standard therapies in reducing cardiac events. In addition, half of the patients enrolled received either a 10- mg dose of atorvastatin or ..

Loading

Article metrics loading...

/content/cardio/13/5/EJC23780
2002-09-01
2016-12-03
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error